Pravastatin has enduring effects on risk of heart disease in menBMJ 2007; 335 doi: https://doi.org/10.1136/bmj.335.7624.797-c (Published 18 October 2007) Cite this as: BMJ 2007;335:797
In 1995, researchers from Scotland reported that a daily dose of pravastatin could help prevent coronary heart disease (CHD) in middle aged men with hypercholesterolaemia. The original trial lasted five years, but the researchers continued to track the men for another 10. The …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial